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Abstract 
Contemporary advances in addiction neuroscience have paralleled increasing interest in the ancient mental training 
practice of mindfulness meditation as a potential therapy for addiction. In the past decade, mindfulness-based inter-
ventions (MBIs) have been studied as a treatment for an array addictive behaviors, including drinking, smoking, opioid 
misuse, and use of illicit substances like cocaine and heroin. This article reviews current research evaluating MBIs as 
a treatment for addiction, with a focus on findings pertaining to clinical outcomes and biobehavioral mechanisms. 
Studies indicate that MBIs reduce substance misuse and craving by modulating cognitive, affective, and psychophysi-
ological processes integral to self-regulation and reward processing. This integrative review provides the basis for 
manifold recommendations regarding the next wave of research needed to firmly establish the efficacy of MBIs and 
elucidate the mechanistic pathways by which these therapies ameliorate addiction. Issues pertaining to MBI treat-
ment optimization and sequencing, dissemination and implementation, dose–response relationships, and research 
rigor and reproducibility are discussed.
Keywords: Automaticity, Addiction, Dissemination, Dose–response, Mindfulness, Review, Reward, SMART
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Advances in biobehavioral science occurring over the 
past several decades have made significant headway in 
elucidating mechanisms that undergird addictive behav-
ior. This large body of research suggests that addiction 
is best regarded as a cycle of compulsive substance use 
subserved by dysregulation in neural circuitry govern-
ing motivation and hedonic experience, habit behavior, 
and executive function [1]. Though findings from the 
basic science of addiction have yielded novel treatment 
targets that may inform the development of promising 
pharmacotherapies, the behavioral treatment develop-
ment process often lags behind the ever-accelerating pace 
of mechanistic discovery. In that regard, the mainstays 
of behavioral addictions treatment, cognitive-behavioral 
therapy and motivational interviewing, were developed 
decades ago and prior to the current understanding of 
addiction as informed by neuroscience. Yet, to the extent 
that behavioral therapies target dysregulated neurocogni-
tive processes underlying addiction, they may hold prom-
ise as effective treatments for persons suffering from 
addictive disorders.
Contemporary developments in addiction neurosci-
ence have been paralleled by increasing interest in the 
age-old mental training practice of mindfulness medi-
tation as a potential treatment for addictive behavior. 
This interest was sparked by the successful integration 
of mindfulness techniques into secularlized behavioral 
intervention programs, including Mindfulness-Based 
Stress Reduction (MBSR) [2] and Mindfulness-Based 
Cognitive Therapy (MBCT) [3]. Standardized mind-
fulness training programs were originally focused on 
reducing emotional distress, and indeed, for psychiatric 
disorders and symptoms mindfulness-based interven-
tions (MBIs) have been shown through meta-analysis 
to be efficacious and comparable to other active, head-
to-head treatments [4]. More recently, MBIs like 
Open Access
Addiction Science & 
Clinical Practice
*Correspondence:  eric.garland@socwk.utah.edu 
1 Center on Mindfulness and Integrative Health Intervention 
Development, University of Utah, 395 South, 1500 East, Salt Lake City, UT 
84112, USA
Full list of author information is available at the end of the article
Page 2 of 14Garland and Howard  Addict Sci Clin Pract  (2018) 13:14 
Mindfulness-Based Relapse Prevention (MBRP) [5] and 
Mindfulness-Oriented Recovery Enhancement (MORE) 
[6] have been tailored to directly to address the mecha-
nisms that undergird addiction. A growing body of con-
trolled research studies demonstrates that MBIs may 
produce significant clinical benefits for users of a panoply 
of addictive substances, including alcohol, cocaine, nico-
tine, and opioids. The aims of this report were to opera-
tionalize the construct of mindfulness with respect to 
therapeutic processes that mediate its potential efficacy; 
review the current state of research on mindfulness as a 
treatment for addiction; and to envision the next wave 
of research in this emerging and important field. With 
regard to setting a future research agenda here we high-
light issues related to: research rigor and reproducibility; 
treatment optimization based on mechanistic discover-
ies; the sequencing of MBIs in multimodal treatment 
packages; the need to consider dose–response relation-
ships; the translation and dissemination of MBIs into 
standard, community-based addiction treatment set-
tings; and the possibility of construing mindfulness as an 
integral component of a recovery-oriented lifestyle rather 
than a time-limited treatment.
Mindfulness as a means of targeting mechanisms 
of addiction
Mindfulness operationalized
Derived from ancient Indo-Sino-Tibetan contemplative 
practices and philosophies concerning the cultivation of 
awareness, the construct of mindfulness has been alter-
nately operationalized as a state, trait, and practice in the 
modern scientific literature. MBIs provide training in 
practices designed to evoke the state of mindfulness—i.e., 
a state of metacognitive awareness characterized by an 
attentive and nonjudgmental monitoring of moment-by-
moment cognition, emotion, sensation, and perception 
without perseveration on thoughts of past and future. 
The practice of mindfulness has been proposed to involve 
two primary elements: focused attention and open moni-
toring [7, 8]. During the practice of focused attention, 
attention is concentrated on a sensory object (often the 
sensation of breathing, but interoceptive and proprio-
ceptive body sensations or external visual foci can also 
be used) while one acknowledges and then disengages 
from distracting thoughts and emotions. Focused atten-
tion practices often precede the practice of open moni-
toring, in which one observes both the arising of mental 
contents as well as the field of awareness in which those 
contents arise [7]. Open monitoring is a metacognitive 
state of awareness in the sense that it involves monitor-
ing the content of consciousness while reflecting back on 
the process or quality of consciousness itself. This form 
of mindfulness practice is thought to reduce emotional 
reactivity by revealing the insubstantiality and ephem-
erality of any particular content of consciousness. Neu-
ropsychological models of focused attention and open 
monitoring have mapped these practices onto systems 
of interacting cognitive processes, including sustained 
attention, attentional re-orienting, conflict monitor-
ing, retaining information online in working memory, 
inhibitory control, and emotion regulation [8]. Although 
focused attention and open monitoring have been dis-
tinguished in the scientific literature, in practice they are 
often combined, such that mindfulness practices typically 
begin with focused attention and then develop into open 
monitoring as the meditation session unfolds over time.
Frequent and regular practice (e.g., daily) of mindful-
ness techniques is thought to cultivate durable changes 
in the trait-like propensity to be mindful in everyday life 
(i.e., dispositional or trait mindfulness) even when one is 
not engaged in meditation practice [9]. This increase in 
trait mindfulness is theorized to occur through neuro-
cognitive plasticity kindled by repeated activation of the 
state of mindfulness during recurrent mindfulness prac-
tice sessions [10]. In partial support of this hypothesis, 
increases in the trajectory of state mindfulness produced 
over time through meditation predicts increases in trait 
mindfulness [11], and meta-analysis demonstrates that 
the effects of MBIs on clinical outcomes are mediated by 
increases in trait mindfulness [12]. Further, meta-analysis 
of morphometric neuroimaging suggests that increased 
practice of mindfulness meditation is associated with 
neuroplastic changes in brain structure [13]. According 
to operationalizations of the construct derived from fac-
tor analytic research, dispositional or trait mindfulness 
is characterized by the capacity to remain nonreactive 
to and accepting of distressing thoughts and emotions; 
observe interoceptive and exteroceptive experience; dis-
criminate emotional states; and be aware of automaticity 
[14]. These mindful qualities may serve as antidotes to 
addictive behavior; indeed, trait mindfulness, which has 
been correlated with enhanced cognitive control capaci-
ties [15], is significantly inversely associated with sub-
stance use [16] and craving [17], and positively associated 
with the ability to disengage attention and recover auto-
nomic function following exposure to addiction-related 
cues [18, 19]. In contrast to trait mindfulness, which 
is associated with cognitive and behavioral flexibility, 
addiction may be characterized by mindlessness [20], i.e., 
habitual or stereotyped responses that may be executed 
automatically without conscious volition or strategic 
regard for distal consequences. In light of Tiffany’s clas-
sic description of addiction as the product of automatic-
ity [21], mindfulness of one’s automatized behavioral and 
emotional reactions may allow for greater self-regulation 
of habitual addictive behavior. Thus, mindfulness practice 
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may evoke the state of mindfulness that accrues with 
each meditation practice session into a durable propen-
sity to exhibit the trait of mindfulness in everyday life, 
thereby suffering as a buffer against addictive behavior.
Mindfulness‑based interventions for addiction
The most prominent MBIs (i.e., MBRP, MORE, mindful-
ness training for smokers) for addiction were modeled 
after the first generation of mindfulness-based thera-
pies like MBSR and MBCT in terms of their structure 
and format. MBIs for addiction tend to be multi-week 
interventions (approximately 8  weeks in duration) usu-
ally delivered in a group therapy format. Each week, 
participants are guided by a trained clinician in vari-
ous mindfulness practices, including mindful breathing 
and body scan meditations. These in-session mindful-
ness practices are debriefed during a subsequent group 
process, after which new psychoeducational material is 
typically presented. Sessions often involve experiential 
exercises to reinforce the mindfulness principles that 
had been introduced didactically. Participants are given 
therapeutic homework, consisting of formal and informal 
mindfulness practices as well as assignments to self-mon-
itor symptoms like craving and negative affect. Extant 
MBIs for addiction differ from one another in terms of 
the types of mindfulness practices taught, the style in 
which these practices are delivered and debriefed (e.g., 
MBRP uses open, non-directive inquiry whereas MORE 
employs a directive approach with a high degree of posi-
tive reinforcement), the length of at home mindfulness 
practice sessions, and the specific psychoeducational 
content delivered.
MBIs for addiction are usually tailored to address path-
ogenic mechanisms implicated in addiction by target-
ing mindfulness techniques to addictive behaviors (e.g., 
mindfulness of craving) and by discussing the applica-
tion of mindfulness skills to cope with addiction in eve-
ryday life. For instance, MORE participants are guided 
to engage in the “chocolate exercise”— an experiential 
mindfulness practice designed to increase awareness of 
automaticity and craving [6]. During this exercise, par-
ticipants are instructed to hold a piece of chocolate close 
to their nose and lips and become mindful of the arising 
of craving as they refrain from eating the chocolate. Dur-
ing this exercise, a comparison is made between the urge 
to swallow the chocolate and craving for addictive sub-
stances. Participants are then guided to adopt a metacog-
nitive stance toward their experience and deconstruct the 
craving into its constituent sensory, affective, and cogni-
tive components, noticing how the craving subsides over 
time. Through this technique, clients learn to consciously 
and adaptively respond to the urge to use substances 
rather than automatically reacting to appetitive cues in 
maladaptive ways. Such tailoring is presumed necessary 
for maximizing clinical effects of MBIs as treatments for 
addiction, though no quantitative comparisons of tai-
lored (e.g., MBRP) versus general (e.g., MBSR) MBIs have 
been conducted for individuals with substance use disor-
ders. Comparative effectiveness research or dismantling 
trials are needed to determine whether such addiction-
specific tailoring increases effect sizes.
Therapeutic mechanisms of mindfulness as a treatment 
for addiction
In a mechanistic theoretical account of mindfulness as 
a treatment for addiction, Garland, Froeliger, & How-
ard conceptualized MBIs as means of mental training 
designed to exercise a number of neurocognitive pro-
cesses that become dysregulated during the process 
of addiction [22]. Such mental training is provided by 
focused attention and open monitoring mindfulness 
practices, which in isolation and in tandem are thought 
to exercise processes crucial to the self-regulation of 
addictive behavior such as attentional re-orienting, meta-
cognition, reappraisal, and inhibitory control [8].
From this perspective, MBIs can been seen as behav-
ioral strategies for strengthening the integrity of pre-
frontally-mediated cognitive control networks that have 
become atrophied by chronic drug use and hijacked 
by drug-related cues and cravings during the process 
of addiction. As adaptive cognitive control is restored 
through mindfulness exercises, MBIs may increase func-
tional connectivity between these top-down prefrontal 
networks and bottom-up limbic-striatal brain circuitry 
involved in reward processing and motivated behav-
ior [22]. Increased connectivity between top-down and 
bottom-up brain networks implicated in addiction (e.g., 
frontostriatal circuitry) may provide the physiological 
substrate through which mindfulness de-automatizes 
addictive behavior. Figure 1 depicts hypothesized neural 
functional mechanisms of MBIs for addiction. By aug-
menting the capacity of the PFC to regulate subcortical 
brain networks in a goal-directed manner, MBIs may 
strengthen a domain general neurocognitive resource 
that can be used to modulate a variety of mechanisms 
implicated in addiction, including reward processing, 
cue-reactivity, stress reactivity, etc. These hypothetical 
behavioral mechanisms are depicted in Fig.  2, and evi-
dence for these mechanisms is reviewed below.
Restructuring reward
Through mechanistic effects of mindfulness-induced 
enhancements in functional connectivity between top-
down and bottom-up brain circuitry, MBIs may reverse 
the allostatic process by which normal reward learning is 
usurped by addictive substances. In that regard, Garland 
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recently advanced a novel hypothesis concerning the 
therapeutic mechanisms of mindfulness for treatment 
of addiction: the restructuring reward hypothesis [23]. 
The restructuring reward hypothesis states that mind-
fulness may reduce addictive behavior by shifting the 
relative salience of drug and natural rewards from valu-
ation of drug-related reward back to valuation of natu-
ral rewards that were salient before the development of 
addiction. Though not the explicit aim of most MBIs, by 
virtue of their effects on enhancing attention regulation 
and positive affect, mindfulness training might nonethe-
less increase pleasure from perceptual and sensorimotor 
experiences in a fashion similar to sensate-focus tech-
niques [24] and promote positive emotion regulation by 
amplifying selective attentional processes [25]. Indeed, 
brief mindfulness practice while eating increased ratings 
of subsequent food liking and enjoyment [26, 27], and 
8-weeks of mindfulness training increased the experience 
of reward derived from pleasant daily life activities [28]. 
This application of mindfulness as a means of appreciat-
ing and focusing on natural rewards is termed savoring 
[29].
Though the aforementioned studies were not directly 
concerned with substance use disorder treatment, a 
mounting body of evidence supports the restructuring 
reward hypothesis and suggests that increasing natural 
reward processing through MBIs might reduce craving 
and addictive behavior. In mechanistic analyses from 
a RCT of MORE as a treatment for prescription opioid 
misuse among chronic pain patients, MORE produced 
significant increases in cardiac-autonomic and electro-
cortical responses to natural reward stimuli that were, in 
Fig. 1 Hypothesized neural mechanisms by which mindfulness-based interventions ameliorate addictive behavior. Garland et al. [20] model of 
mindfulness-centered regulation posits that mindfulness-based interventions ameliorate the craving, negative affective states, and automatic habit 
behaviors underpinning addiction by enhancing functional connectivity (1) within a “top-down” brain network subserving metacognitive atten-
tional (dlPFC, dACC, parietal cortex) and (2) between this metacognitive attentional control network and “bottom-up” brain structures implicated 
in automaticity, memory consolidation, interoception, and hedonic regulation. Enhanced functional connectivity within and between these neural 
circuits may allow individuals to self-regulate addictive impulses and restructure reward processes to support healthy, goal-oriented behavior. dlPFC 
dorsolateral prefrontal cortex, dACC dorsal anterior cingulate cortex, PCC posterior cingulate cortex, DS dorsal striatum, VS ventral striatum, Thal 
thalamus, HIPP hippocampus, Amy amygdala, OFC orbitofrontal cortex, MFC medial prefrontal cortex
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turn, associated with decreases in opioid craving [30, 31], 
suggesting that MBI may restructure reward processing. 
Further, recent analyses indicate that MORE enhances 
autonomic responses to natural reward cues relative to 
opioid cues, and increases in relative physiologic respon-
siveness to natural versus opioid-related reward signifi-
cantly predicted reduced opioid misuse 3  months later 
[32]. These psychophysiological findings converged with 
ecological momentary assessment data collected dur-
ing this trial, which indicated that MORE significantly 
increased the trajectory of positive affect from moment-
to-moment which in turn predicted decreased opioid 
misuse following treatment [33].
These findings supporting of the restructuring reward 
hypothesis were paralleled by preliminary functional 
magnetic resonance imaging (fMRI) evidence of the 
effects of MORE on nicotine dependent smokers. In a 
pilot study of MORE as a smoking cessation intervention 
[34], smokers viewed cigarette images during a cue-reac-
tivity task, and then in a separate positive emotion regu-
lation task, either viewed or savored images representing 
natural rewards. Relative to a time matched comparison 
group, participants in MORE exhibited significant pre-
post treatment reductions in ventral striatal responses to 
cigarette cues over time, and significant increases in ven-
tral striatum and rostral anterior cingulate cortex (rACC) 
during savoring of natural reward stimuli. Furthermore, 
resting state functional connectivity between rACC and 
orbitofrontal cortex (OFC) significantly increased in the 
MORE group relative to the comparison group. These 
increases in functional connectivity, striatal, and rACC 
savoring responses significantly predicted increases in 
positive affect and reductions in the quantity of cigarettes 
smoked over the course of treatment with MORE, sug-
gesting that mindfulness training may treat addiction by 
restructuring function of brain reward circuitry. To be 
clear, MORE provides integrated training in mindfulness, 
reappraisal, and savoring skills, and therefore other MBIs 
may or may not exert similar effects on restructuring 
the relative salience of natural and drug-related reward. 
However, other potential mechanisms of mindfulness as 
a treatment for addiction have been identified in the lit-
erature and are discussed below.
Executive functioning
By strengthening top-down cognitive control, MBIs may 
improve executive functions like self-control over auto-
matic habits, decision-making, and response inhibition 
that are crucial to reducing drug use and maintaining 
abstinence. In that regard, a small quasi-experimental 
study of a mindfulness and goal management training 
intervention for polysubstance use demonstrated signifi-
cant improvements in executive functioning, including 
working memory, selective attention/response inhibition 
and decision-making skills following mindfulness train-
ing relative to treatment as usual [35]. A subsequent pilot 
Fig. 2 Schema detailing the effects of mindfulness-based intervention components on mechanisms and outcomes implicated in the treatment of 
addictive behavior
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RCT with a sample of polysubstance users replicated 
these effects of combined goal management and mind-
fulness training in laboratory-based tasks and ecologi-
cally valid measures of decision-making [36]. Similarly, 
in a full-scale clinical trial, mindfulness-based addiction 
treatment significantly improved smoking abstinence by 
decreasing concentration difficulties [37]. In addition, 
there is some evidence that MBIs for addiction increase 
activation in brain regions implicated in self-regulatory 
executive functions: a small RCT showed that 2  weeks 
of mindfulness training was associated with significant 
reductions in smoking coupled with increased resting 
state activity in the ACC and mPFC [38]. Such increased 
prefrontal activation might facilitate mindfulness-
induced deautomatization of addictive responses.
Dispositional mindfulness
MBIs might also reduce addictive behavior by strength-
ening facets of dispositional/trait mindfulness. In a RCT 
of MBRP among a heterogenous sample of individuals 
with various substance use disorders, increases in dispo-
sitional mindfulness facets like acceptance, awareness, 
and nonjudgment significantly mediated the effect of 
MBRP on decreasing craving following treatment [39]. 
Similarly, in a large cluster RCT of MORE versus CBT or 
TAU, increases in dispositional mindfulness significantly 
mediated the effect of MORE on reducing craving follow-
ing treatment [40]. Finally, MORE significantly increased 
the mindfulness facet of nonreactivity which, in turn, 
predicted decreases in prescription opioid misuse [41].
Stress reactivity and stress recovery
Given known linkages between stress and addiction [42, 
43], MBIs might ameliorate addictive behavior by atten-
uating stress reactivity and augmenting stress recov-
ery. Several studies of MBIs as treatments for addiction 
have employed measures of heart rate variability (HRV), 
the beat-to-beat variation in heart rate driven by the 
parasympathetic nervous system [44], as an index of the 
capacity to regulate physiological reactivity and recovery 
from stress. In a sample of individuals receiving treatment 
for substance use disorders, relative to a control group 
and treatment-as-usual, MBRP was associated with sig-
nificantly greater increases in tonic HRV and phasic HRV 
responses to stress [45]. Similarly, a mindfulness training 
intervention based on MBRP for individuals with alcohol 
and/or cocaine use disorders was associated with signifi-
cantly attenuated sympathovagal HRV ratio during stress 
exposure [46]. Among nicotine-deprived smokers, brief 
mindfulness training was associated with significantly 
greater HRV during stress exposure than a control con-
dition [47]. In a pilot RCT, compared to an active con-
trol group, participation in MORE was associated with 
significantly greater HRV recovery from stress-primed 
alcohol cues that were coupled with significantly greater 
reductions in cue-induced distress over the recovery 
period [48]. With regard to stress biomarker measures, 
one study found that mindfulness training for smokers 
was associated with significant within-group decreases 
in hair cortisol measures [49], and an nonexperimental 
study of MBSR found significant within-group decreases 
in awakening salivary cortisol levels among participants 
receiving inpatient treatment for substance use disor-
ders [50]. To date, only one study has examined brain 
mechanisms of the stress regulatory effects of MBIs: in 
a RCT, an 8-week MBI for smoking cessation was asso-
ciated with significantly less amygdala and insula activa-
tion during stress exposure relative to an active control 
condition, and reduced activity in these brain regions was 
associated with decreased smoking by follow-up [51].
Craving and cue‑reactivity
MBIs may reduce addictive behavior by decreasing sub-
jective craving and attentional and physiological indices 
of drug cue-reactivity. In addition to the aforementioned 
smoking cessation study in which MORE reduced striatal 
responses to cigarette cues [34], decreased cue-reactivity 
was observed in an RCT in which MORE was shown to 
significantly reduce attentional bias toward opioid cues 
[52] and decrease subjective craving responses during 
an opioid cue-reactivity protocol [30]. Similarly, in a lab-
based brief mindfulness induction, mindful attention 
to smoking cues significantly reduced craving coupled 
with decreased activation in a craving-related region of 
the subgenual ACC [53]. These lab-based assessments 
of craving as a mediator of MBI effects have been cor-
roborated by clinical research: in a large clinical trial, 
the effects of mindfulness-based addiction treatment on 
smoking abstinence were mediated by decreased crav-
ing [37]. Similarly, a study of mindfulness training for 
smokers found that mindfulness significantly reduced 
post-quit smoking urge ratings that were significantly 
associated with smoking abstinence [54]. In addition to 
targeting craving, mindfulness training aims to reduce 
cognitive, affective, and behavioral reactivity. In the con-
text of addiction, substance use is often a reaction to 
increases in negative affect and craving. Thus, MBIs may 
undo this reaction by decoupling affective response and 
craving from substance use. For example, brief instruc-
tion in mindfulness as a means of coping with urges to 
smoke attenuated the association between negative affect 
and smoking urges [55]. With regard to longer MBI pro-
grams, MBRP has been shown to decouple associations 
between depressed mood, craving, and substance use; 
MBRP significantly reduced the association between 
postintervention depressive symptoms and craving 
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2  months following treatment, which in turn predicted 
reduced substance use at 4-months follow-up [41, 56]. 
A mindfulness-based smoking cessation intervention 
derived from MBRP significantly reduced the associa-
tion between craving and cigarette smoking [57]. In the 
same vein, MORE significantly attenuated the association 
between prescription opioid craving and opioid misuse.
Thought suppression
Finally, given that suppression of addictive urges exhausts 
autonomic resources for self-control [58] and paradoxi-
cally amplifies craving [59], MBIs may reduce addictive 
behavior by providing an effective alternative to thought 
suppression. In support of this notion, a quasi-experi-
mental study of incarcerated substance users found that 
decreases in thought suppression mediated the effect 
of mindfulness training (i.e., Vipassana meditation) on 
reducing alcohol use [60]. Similarly, in a pilot RCT of 
alcohol dependent inpatients, MORE was shown to sig-
nificantly reduce thought suppression which was in turn 
associated with reductions in alcohol attentional bias 
[48].
Though mechanistic research on MBIs has begun to 
amass, there are few psychophysiological and neuroim-
aging studies of MBIs as a treatment for addiction. Thus 
little data exists to either support or refute the neural 
mechanistic models proposed in this section. Clearly, 
more research is needed in this area.
Current state of the field: a review of clinical 
outcomes of mindfulness‑based treatments 
for addiction
A considerable body of findings has amassed supporting 
the capacity of MBIs to reduce substance use and attenu-
ate factors promoting substance use, such as craving and 
stress. Over the past decade, multiple systematic reviews 
have been conducted to identify the effects of MBIs on 
addictive behaviors, and have found accumulated evi-
dence for the positive effects of MBIs [61–63]. More 
recently, a meta-analysis focused on the broad clinical 
efficacy of MBIs for a range pf psychiatric disorders con-
ducted subgroup analyses to examine the effects of MBIs 
on addiction/smoking and found MBIs to be superior to 
active control conditions and comparable to other evi-
dence-based treatments [4]. In the only published meta-
analysis solely focused on MBIs for substance misuse, 
Li, Howard, Garland, McGovern, and Lazar [64] identi-
fied 34 randomized controlled trials differing in terms 
of the types of MBI and comparison groups contrasted, 
sample demographics, and measures of outcomes and 
other constructs. Despite the notable methodological 
heterogeneity of these investigations, the authors con-
cluded that “virtually all studies found that mindfulness 
treatments were associated with superior treatment out-
comes at posttreatment and follow-up assessments com-
pared to comparison conditions” (p. 69). Effects (Cohen’s 
d/odds ratios) ranged from moderate-to-large across the 
synthesized effect sizes computed for studies within the 
substance use (d = 0.33, − 0.49 to 0.17, p < 0.05), ciga-
rette smoking (OR = 1.76, 0.99–3.15, p = 0.056), craving 
(d = 0.68, − 1.11 to − 0.025, p < 0.01), and stress (d = 1.12, 
− 2.24 to –0.01, p < 0.05) domains.
With regard to secondary or mechanistic outcomes, 
as expected, MBIs produced significant increases on 
the Five Factor Mindfulness Questionnaires in all eight 
studies that used this measure (d = 0.62, − 0.02 to 1.26, 
p = 0.057). In individual studies, MBIs produced a host 
of other significant salutary effects including increases 
in emotion regulation [41, 54], substance-related self-
efficacy [65, 66], and positive emotions [33], as well as 
decreases in attentional bias [52, 66, 67], addictive auto-
maticity [66], dysphoric affect [40, 66], and pain sever-
ity and related functional interference in patients with 
chronic pain [41]. Several studies reported positive 
associations between the degree to which participants 
engaged in mindfulness homework exercises and changes 
in cigarette, marijuana, and alcohol use posttreatment 
(e.g., [68–70]).
Of the 34 RCTs reviewed in this meta-analysis, ten used 
treatment-as-usual comparison groups, whereas two 
used inert comparison groups, sixteen employed an alter-
native psychotherapeutic treatment (typically matched to 
the MBI group vis-à-vis intensity, duration, and format), 
and six examined brief mindfulness treatments compared 
to alternative therapies in laboratory settings. Twenty-
eight of the reports presented the first published findings 
from the related study and six reports presented results 
of secondary analyses. Any given study could contribute 
findings only once to meta-analyses conducted within 
outcome domains. The adequacy of randomization was 
examined in all studies and analysis of covariance and 
linear mixed modeling were often used to control for 
any remaining pretreatment differences. Nearly half of 
the studies had samples sizes less than fifty. Many studies 
had high attrition rates at posttreatment and subsequent 
follow-ups. Most of the 34 studies reviewed relied exten-
sively on self-report measures of substance use and other 
constructs. All RCTs examined were single-site stud-
ies. The most common methodological limitations were 
failure to interview collateral informants regarding study 
participants’ substance use behaviors at posttreatment 
and follow-up and to employ posttreatment and follow-
up interviewers who were blind to participants’ treat-
ment assignments. Fewer than half of the RCTs employed 
objective verification of participants’ self-reported sub-
stance use, such as urinanalysis.
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Subgroup analyses within outcome domains indicated 
that MORE treatment was associated with larger effects 
than other MBIs for substance use, craving, stress, and 
mindfulness measures [64]. Studies comprised entirely 
of men also reported larger effects for MBIs compared to 
studies with samples comprised only of women or those 
with mixed gender samples across measures of craving, 
stress, and mindfulness.
Li et  al. [64] also reported findings from a random 
effects meta-regression analysis examining effects of MBI 
type, primary type of substance misused, study sample 
size, sample age and gender distributions, type of com-
parison group, treatment dosage in hours, and study 
methodological rigor on effect sizes by domain. Results 
indicated that studies with samples of only men experi-
enced larger reductions in levels of craving and stress, 
and significantly larger increases in levels of mindful-
ness, compared to studies with samples comprised only 
of women or studies with samples comprised of women 
and men. Although the authors did not include a formal 
search for “gray literature” related to MBI treatment of 
substance misuse, they noted that funnel plots and Egg-
er’s test analyses suggested that their findings were not 
likely due to publication bias.
Randomized controlled trials suggest that MBIs are a 
promising treatment for substance misuse and exert their 
effects via increases in levels of mindfulness across a wide 
array of substance-misusing behaviors and clinical popu-
lations. Future research should employ larger samples, 
longitudinal designs with follow-up periods of at least 
1-year, manualized interventions with treatment fidelity 
assessment, intent-to-treat analyses, and probability sam-
pling designs allowing generalizability to specific clinical 
and general populations.
Laying out a research agenda
Research rigor and reproducibility
MBIs are promising treatments for addiction. Results 
from rigorous, full-scale RCTs indicate that MBIs can 
produce short and long-term reductions in craving and 
addictive behavior. At this juncture in the development 
of the field, additional Stage III and IV clinical trials (for 
a review of the NIH Stage Model, see [71]) are needed 
to replicate these promising findings via gold-standard 
research design features including the use of active con-
trol conditions, detailed fidelity monitoring procedures, 
and triangulation of self-reported outcomes with bio-
chemical verification of drug use and blinded clinical 
evaluations. With additional replications of positive 
clinical outcomes, MBIs could rightfully be considered 
empirically-supported therapies for addictive behaviors. 
Conversely, replication failures could indicate the need 
to “return to the drawing board” and engage in treatment 
development research to optimize the next generation of 
MBIs as interventions for addiction. Thus, in the lifespan 
of this nascent field, it is now an opportune moment to 
answer definitively the question “Are MBIs efficacious 
and comparatively effective treatments for addiction?”
Assuming an affirmative answer to the aforementioned 
question, studies should then aim to address research 
questions pertaining to mediation (“How do MBIs 
improve addiction-related outcomes?”) and moderation 
(“For whom do MBIs work most optimally to improve 
addiction-related outcomes?”). As discussed in “Mind-
fulness as a means of targeting mechanisms of addiction” 
section, a corpus of research has begun to amass on the 
mediators of MBI effects on addiction. In contrast, there 
is very little research on moderators of MBIs. The only 
study of MBI moderators for addiction outcomes is a sec-
ondary analysis of data from two RCTs of MBRP, which 
found that patients with greater substance use disorder 
severity and more affective symptoms received signifi-
cantly greater benefit from mindfulness training than 
patients with low levels of substance use and affective 
symptoms [72].
A number of additional research questions remain 
unanswered. Here we lay out an agenda for the next wave 
of research in the field.
Elucidating the neurobiological mechanisms 
of mindfulness as a treatment for addiction
Little is known about the neurobiological mechanisms of 
mindfulness as a treatment for addiction. Though various 
conceptual models have been advanced [22, 23, 73], few 
tests of these specific neural hypotheses have been con-
ducted. Adequately powered, randomized fMRI studies 
are needed to test basic mechanistic assumptions long 
held in the field. For instance, do MBIs decrease addic-
tive behavior by strengthening inhibitory control via acti-
vation of top-down neural circuitry? Do MBIs decrease 
addictive behavior by reducing activation of bottom-up 
neural circuitry to drug cues? Similarly, functional neu-
roimaging methods are needed to test novel hypoth-
eses, such as the restructuring reward hypothesis (“Do 
MBIs restructure the relative responsiveness to drug and 
natural rewards by increasing functional connectivity 
between top-down and bottom-up neural circuits?”). Fur-
thermore, molecular neuroimaging (e.g., positron emis-
sion tomography; PET) is needed to understand effects 
of MBIs on neurotransmitters and neuropeptides impli-
cated in addictive behavior like dopamine, endogenous 
opioids, γ-aminobutyric acid (GABA), and endocannabi-
noids. Finally, dynamic effects of mindfulness practice 
on addictive responses are unknown, and could be eluci-
dated through functional neuroimaging techniques with 
high temporal resolution like electroencephalography 
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(EEG) or magnetoencephalography (MEG). Such meth-
ods could answer other pertinent questions. For instance, 
does the acute state of mindfulness attenuate initial 
attentional orienting to drug cues? Or, does mindfulness 
facilitate attentional disengagement and recovery from 
drug cue-exposure? These questions can be answered 
by investigating how mindfulness training influences the 
time course of neural responses to drug cues.
Although understanding treatment mechanism is not 
necessary to establish a given treatment modality as an 
empirically supported intervention, understanding the 
mechanisms of mindfulness can inform the refinement of 
MBIs to yield larger effect sizes and produce additional 
therapeutic benefits. A case in point is MORE, which 
was refined based on mechanistic discoveries. Follow-
ing the first trial of MORE, it was found that mindfulness 
reduces pain severity by fostering a shift from affective to 
sensory processing of pain as innocuous sensory infor-
mation [74]. As a result of this discovery, when MORE 
was optimized as a treatment for prescription opioid 
misuse among chronic pain patients, the intervention 
was modified to include a “mindfulness of pain” tech-
nique that involved using mindfulness to deconstruct 
pain into its sensorial subcomponents and disentangle 
sensation from its affective overlay. Similarly, evidence 
that increasing physiological responsiveness to natural 
rewards via mindful savoring predicts decreased pre-
scription opioid misuse [75] and craving [30] has led to 
an enriched emphasis on mindful savoring practice in the 
MORE intervention. It is possible that these intervention 
refinements may account for the changes in brain reward 
circuitry function observed among smokers treated with 
MORE [34]. As another example, recent investigation of 
the role of the posterior cingulate cortex in meditation 
experience has implicated this brain region as a target for 
neurofeedback interventions to potentiate the efficacy 
of MBIs [76], and indeed, trials of such neurofeedback-
enhanced MBIs are underway (e.g., NCT02413177).
Sequencing of mindfulness as a part of multimodal 
treatment packages
It is not known whether MBIs are most efficacious as 
standalone treatments or as a part of a more compre-
hensive treatment package. In many inpatient addic-
tions treatment programs, clients receive multiple 
behavioral interventions (e.g., motivational enhance-
ment therapy, cognitive-behavioral therapy, dialectical 
behavior therapy) during the same 30-day time frame. 
Further, optimal treatment sequencing has not been 
studied. For instance, would MBIs be more efficacious 
following several sessions of motivational interview-
ing? Given that MBIs involve mindfulness practice, and 
regular practice requires motivation, introducing several 
sessions of motivational interviewing before initiating a 
course of mindfulness training might increase practice 
engagement and thereby boost clinical outcomes. Con-
versely, mindfulness training might potentiate motiva-
tional enhancement therapy by increasing interoceptive 
awareness of adverse consequences of addictive behavior 
on bodily health. In a similar vein, mindfulness training 
might increase adherence to medication-assisted ther-
apy (MAT) by increasing awareness of how medication 
adherence allays the dysphoria associated with craving 
and thereby potentially improves quality of life. In turn, 
MAT might improve adherence to MBIs by attenuat-
ing distracting withdrawal symptoms and decreasing 
obsessive thinking about obtaining the next drug dose, 
thereby freeing cognitive and motivational resources to 
devote to learning mindfulness skills. Psychopharmaco-
logical interventions, cognitive training via computer- or 
smartphone-deployed technology, neurofeedback, and 
neurostimulation (via transcranial magnetic stimulation 
or transcranial direct current stimulation) administered 
prior to initiating a course of MBI might also improve 
cognitive function to facilitate learning of mindfulness 
techniques, and thereby improve MBI outcomes.
Sequential, multiple assignment, randomized trials 
(SMART) could be used to assess the efficacy of dynamic 
treatment regimens, including those that are individually 
tailored based on decision rules that dictate how the type 
or dosing of treatment should change based on the spe-
cific clinical needs of the patient [77]. For instance, MBI 
non-responders might need a supplementary course of 
motivational enhancement therapy, computerized cogni-
tive remediation, or booster sessions (see “The Need for 
Dose/Response Research” below) to enhance outcomes. 
Finally, given that many MBIs are multimodal in nature 
and combine various mindfulness meditation practices 
and psychoeducational modules, studies that employ the 
multiphase optimization strategy (MOST) could also be 
used to examine the independent and additive effects of 
various MBI treatment components on addictive behav-
iors [78]. The MOST research process could allow for 
resource-intensive and complex MBIs to be pared down 
to their most efficacious elements to maximize efficacy 
and efficiency by eliminating techniques that do not con-
fer therapeutic benefits and augmenting those that do.
The need for dose–response research
In pharmacological research, it is imperative to examine 
dose–response relationships to identify the optimal ther-
apeutic dose. Dose–response curves can help to identify 
the dose needed to achieve a satisfactory clinical out-
come while minimizing the side-effect profile of the drug. 
Although MBIs delivered in clinical settings appear to 
have few adverse effects [79], the costs and time required 
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to deliver complex behavioral treatments like MBIs 
necessitate dose–response considerations to identify the 
minimal therapeutic dose. Null effects of MBIs observed 
in Stage II or III clinical trials might very well be qualified 
by extent of mindfulness practice, and thus mindfulness 
practice engagement should be tested as a treatment out-
come moderator. Furthermore, responder analyses might 
reveal that individuals classified as non-responders are 
those who do not meet the minimal therapeutic dose of 
mindfulness skill practice whereas individuals classified 
as responders are those who surpass this minimal thera-
peutic dose of practice.
Given meta-analytic findings that extent of mindful-
ness practice is significantly associated with treatment 
outcomes [80], different doses of mindfulness practice 
might produce different therapeutic effect sizes or differ-
ent durations of therapeutic effects for addicted popula-
tions. Most MBIs for addictive disorders (e.g., MBRP and 
MORE) are approximately 2 months in length given that 
they were modeled on the canonical 8-week structure 
of MBSR [81]. However, due to their clinical complex-
ity, individuals with substance use disorders are typically 
excluded from participating in MBSR. Although MBIs 
like MORE and MBRP have produced significant reduc-
tions in addictive behaviors [64], it is plausible that to 
achieve full remission from moderate-to-severe sub-
stance use disorder, patients might require additional 
weekly treatment sessions beyond the standard 8-weeks 
of treatment. Moreover, following a full course of a multi-
week MBI, periodic booster sessions might be needed 
to extend treatment benefits for the long-term. Such 
booster sessions could come in the form of mindfulness 
practice sessions (with or without group process and psy-
choeducational content) conducted via in-person or tel-
emedicine formats, and their additive efficacy could be 
tested with SMART research designs.
The challenge of dissemination/implementation
One of the greatest challenges confronting the movement 
towards evidence-based practice in addictions treat-
ment is the research-to-practice gap: that is, empirically-
supported therapies with proven efficacy as revealed 
by Stage II randomized clinical trials are often not suc-
cessfully translated into effective clinical interventions 
in standard addiction practice settings [82]. Successful 
transfer of research to practice involves programmatic 
change in the form of activities including exposure, adop-
tion, implementation, and practice of new empirically-
supported approaches [83]. These activities are especially 
complicated in the context of MBI implementation, inso-
far as many common MBIs require intensive instructor 
training. For example, the MBSR certification process 
costs more than $10,000 and requires approximately 
3  years to complete depending on how long it takes a 
prospective instructor to meet the requirements, which 
include personal practice and participation in multi-day 
meditation retreats, didactic and experiential workshop 
training, experience leading multiple MBSR groups, and 
clinical supervision [84]. Further complicating this issue, 
individuals without clinical licensure can be certified in 
MBSR, yet most addictions treatment settings require 
staff to be licensed healthcare professionals. In contrast, 
other MBIs like MORE require clinical licensure but 
entail a much briefer and less costly training process. It 
remains an open question for future research as to how 
much clinical training, supervision, and personal prac-
tice experience is required for effective implementation 
of MBIs in clinical settings. Moreover, it is not known 
which training formats are most effective (in person, 
online, role play, virtual reality, etc.) in disseminating 
MBIs. Issues around treatment fidelity are also crucial 
to successful implementation of MBIs in clinical prac-
tice. However, few fidelity measures have been validated 
for MBIs for addiction (for a notable exception, see 85), 
treatment fidelity research is time intensive, and little is 
known about empirical relations between clinician train-
ing format, therapist adherence/competence, and MBI 
treatment outcomes. Similarly, the acceptability of MBIs 
may influence their implementation in clinical practice 
settings. Factors influencing the acceptability of MBIs 
for the treatment of addiction are poorly understood. 
For instance, it is plausible that patients who initially 
experience mindfulness meditation as rewarding (i.e., 
alleviating psychological distress and generating positive 
sensations and emotions) or who are positively reinforced 
by the therapist for engaging in meditation practice may 
be most likely to continue to practice mindfulness skills. 
In contrast, patients who experience an exacerbation 
of aversive thoughts and feelings during meditation or 
who receive neutral responses from the therapist might 
be most likely to drop out from an MBI. Moreover, non-
specific factors like therapeutic alliance, and allegiance 
might drive MBI acceptability, adherence, and outcome 
in a similar fashion to other behavioral therapies. Stra-
tegic attention to such factors might in fact boost the 
uptake and clinical efficacy of MBIs.
In outlining issues pertaining to advancing the clinical 
science of MBIs, Dimidjian and Segal highlight the ten-
sion between the need to make MBIs disseminable in the 
context of real-world resource constraints and complex 
client populations while not allowing outcomes to suf-
fer as MBIs are scaled up in the translation to commu-
nity treatment settings [86]. This is indeed a challenge, 
as MBIs with demonstrated efficacy in Stage II trials may 
fail to show effectiveness in Stage III and IV trials when 
delivered by community clinicians. Yet, work now needs 
Page 11 of 14Garland and Howard  Addict Sci Clin Pract  (2018) 13:14 
to be done to understand the feasibility, acceptability, 
and impact of delivering MBIs in addiction treatment 
settings.
Mindfulness as a relapse prevention strategy 
versus mindfulness as a vehicle for recovery
Finally, it is unknown whether mindfulness might best 
ameliorate addiction through participation in time-lim-
ited interventions or if mindfulness should be used daily 
as part of a wellness lifestyle. With regard to the latter, 
shifting from an addiction-oriented lifestyle to adoption 
of a wellness lifestyle is conceptualized as integral to the 
recovery model [87]. In this vein, studies should examine 
mindfulness not only as a technique in circumscribed 
interventions to prevent addiction relapse but also 
examine mindfulness as a long-term, sustainable health 
behavior that promotes addiction recovery. Pursuit of a 
healthy lifestyle is not something that is finalized over the 
course of an 8-week intervention; to the contrary, main-
tenance of physical health requires ongoing, regular exer-
cise and nutritious dietary choices on a daily basis that 
do not exceed the caloric needs of the individual. Why 
then should mindfulness practice be any different? As a 
point of consideration, 12-Step programs encourage par-
ticipation in regular meetings for the entirety of one’s life. 
Similarly, mindfulness might need to be practiced daily 
or nearly every day on an ongoing basis to achieve dura-
ble therapeutic effects and maintain addiction recovery, 
especially in view of the chronicity of addictive disorders.
From a neurobiological perspective, increasing grey 
matter density, strengthening of white matter tracts, 
synaptic remodeling, and other neuroplastic modifica-
tions to brain structure and function needed to undo the 
pathophysiology of addiction might require recurrent 
mindfulness practice for the long-term. From a psycho-
logical perspective, long-term mindfulness practice may 
be needed to induce self-referential plasticity and facili-
tate flexible reconfiguration of the self-schema in relation 
to the world [88] so as to restructure reward processes 
away from valuation of drug reward and towards valua-
tion of personally meaningful pursuits and relationships 
[23, 29]. This latter process is consistent with the ancient 
soteriological intention of mindfulness as a means of 
reducing craving by gaining insight into the true nature 
of the self as impermanent and interdependent [89]—
paralleling Bateson’s classical cybernetic model of addic-
tion recovery [90].
Conclusion
The study of mindfulness as a treatment for stress and 
chronic pain is more than 30  years old, and research-
ers have investigated mindfulness as a treatment for 
depression for more than two decades, yet it is only in 
the past 10  years that research on MBIs for addiction 
has proliferated. This is a young scientific field, and more 
research is needed to elucidate the clinical outcomes and 
mechanisms of this promising new treatment approach 
for addictive disorders. One recent meta-analysis [64] 
indicates that MBIs produce statistically significant 
effects on craving (pooled Cohen’s d = 0.68) and sub-
stance misuse (pooled Cohen’s d = 0.33), suggesting that 
MBIs may be efficacious treatments for addiction. Over-
all, a number of RCTs with active control conditions 
have been conducted in the past decade—a sign that the 
methodological rigor of this field is increasing. However, 
with several notable exceptions (e.g., [40, 91, 92]), few 
studies of MBIs for addiction have had large enough sam-
ple sizes to ensure the robustness and reproducibility of 
clinical outcomes. Moreover, few long-term follow-ups 
have been conducted to assess the durability of observed 
treatment effects. In addition, as indicated earlier, little 
is known about mediators and moderators of MBIs for 
addiction, although understanding how and for whom 
MBIs work is crucial to the overall evolution of this ther-
apeutic approach. Lastly, research is needed to situate 
MBIs into treatment sequences with high external valid-
ity that adaptively address the needs of responders and 
non-responders in a way that can be realistically imple-
mented in community-based treatment settings. Thus, 
the nascent field of mindfulness treatment for addictive 
behaviors remains open to rigorous, scientific explora-
tion and in need of innovative research questions and 
methodologies.
Coming full circle, MBIs are some of the newest addi-
tions to the armamentarium of addictions treatment. It 
is perhaps no coincidence that the rise of MBIs has been 
co-incident with advances in the neuroscience of sub-
stance use disorders. In recognizing that addiction is, in 
large part, mediated by cognitive and behavioral auto-
maticity propelled by alterations to hedonic regulatory 
systems in the brain, this perennial form of human suffer-
ing may be especially tractable to treatment approaches 
like mindfulness that enhance top-down conscious con-
trol over bottom-up automatic habits and motivational 
drives. Insofar as the original purpose of many mindful-
ness meditation practices was to extinguish craving by 
revealing the “middle way” between attachment to pleas-
ure and aversion to pain, MBIs may ultimately provide a 
skillful means of liberating the individual from the push 
and pull of hedonic dysregulation underlying addiction.
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